Chemed Assets & Liabilities Overview 2010-2023 | CHE

Current and historical assets & liabilities overview for Chemed (CHE) from 2010 to 2023.
Chemed Annual Assets & Liabilities Overview
(Millions of US $)
Chemed Quarterly Assets & Liabilities Overview
(Millions of US $)
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $8.503B $2.264B
Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.269B 10.45
Quest Diagnostics (DGX) United States $15.262B 15.77
DaVita (DVA) United States $11.791B 14.65
Encompass Health (EHC) United States $8.378B 21.45
Elanco Animal Health (ELAN) United States $6.685B 15.20
Option Care Health (OPCH) United States $5.181B 19.61
RadNet (RDNT) United States $3.783B 102.40
Amedisys (AMED) United States $3.009B 21.32
LifeStance Health (LFST) United States $2.546B 0.00
Astrana Health (ASTH) United States $2.099B 26.20
Addus HomeCare (ADUS) United States $1.608B 24.43
U.S Physical Therapy (USPH) United States $1.585B 41.09
Pennant (PNTG) United States $0.642B 37.54
Aveanna Healthcare Holdings (AVAH) United States $0.448B 0.00
Atai Life Sciences (ATAI) Germany $0.343B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.026B 0.00
ATI Physical Therapy (ATIP) United States $0.019B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.011B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00